tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Protalix: Pipeline Expansion and Elfabrio Growth Drive Attractive Risk‑Reward and Undervalued Buy Rating
PremiumRatingsProtalix: Pipeline Expansion and Elfabrio Growth Drive Attractive Risk‑Reward and Undervalued Buy Rating
3M ago
Protalix, Secarna Pharmaceuticals enter collaboration and option agreement
Premium
The Fly
Protalix, Secarna Pharmaceuticals enter collaboration and option agreement
3M ago
Protalix price target lowered to $12 from $15 at H.C. Wainwright
Premium
The Fly
Protalix price target lowered to $12 from $15 at H.C. Wainwright
4M ago
Protalix Seeks EMA Re-examination for Elfabrio Dosing
PremiumCompany AnnouncementsProtalix Seeks EMA Re-examination for Elfabrio Dosing
4M ago
Protalix Faces EMA Setback on Elfabrio® Dosing
Premium
Company Announcements
Protalix Faces EMA Setback on Elfabrio® Dosing
5M ago
Protalix, Chiesi Global: CHMP issues negative opinion for Elfabrio
Premium
The Fly
Protalix, Chiesi Global: CHMP issues negative opinion for Elfabrio
5M ago
Is PLX a Buy, Before Earnings?
PremiumPre-EarningsIs PLX a Buy, Before Earnings?
7M ago
Protalix Lawsuit Dismissed After Bylaws Amendment
Premium
Company Announcements
Protalix Lawsuit Dismissed After Bylaws Amendment
7M ago
Protalix Appoints New CFO to Boost Growth Strategy
Premium
Company Announcements
Protalix Appoints New CFO to Boost Growth Strategy
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100